Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Chemotherapy-Induced Depression and Anxiety in Breast Cancer
NCT02203552Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jun 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in major depressive disorder (MDD), anxiety disorder, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Jun 2015; status: completed.
02
Drugs
minocycline
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT02203552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203552.